EC Number | Application | Comment | Organism |
---|---|---|---|
1.4.3.4 | medicine | the monoamine oxidase inhibitor rasagiline may provide a much lower risk of serotonin syndrome than the monoamine oxidase inhibitor selegiline in parkinsonian patients treated with an serotonin reuptake inhibitor | Rattus norvegicus |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
1.4.3.4 | rasagiline | - |
Rattus norvegicus | |
1.4.3.4 | selegiline | - |
Rattus norvegicus |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.4.3.4 | Rattus norvegicus | P19643 | - |
- |
1.4.3.4 | Rattus norvegicus | P21396 | - |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
1.4.3.4 | brain | - |
Rattus norvegicus | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.4.3.4 | phenylethylamine + H2O + O2 | - |
Rattus norvegicus | 2-phenylethanal + NH3 + H2O2 | - |
? | |
1.4.3.4 | serotonin + H2O + O2 | - |
Rattus norvegicus | (5-hydroxy-1H-indol-3-yl)acetaldehyde + NH3 + H2O2 | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
1.4.3.4 | MAO-A | - |
Rattus norvegicus |
1.4.3.4 | MAO-B | - |
Rattus norvegicus |